{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:56:45Z","timestamp":1793451405224,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jacc.2024.09.1227","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T09:03:22Z","timestamp":1731661402000},"page":"322-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["P2Y12 Inhibitor Pretreatment in Non\u2013ST-Segment Elevation Acute\u00a0Coronary Syndrome"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-7193","authenticated-orcid":false,"given":"Hiroki A.","family":"Ueyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Rymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.09.1227_bib1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.jacc.2014.09.016","article-title":"2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes: executive summary","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2022.10.023","article-title":"Timing, selection, modulation, and duration of P2Y12 inhibitors for patients with acute coronary syndromes undergoing PCI","volume":"16","author":"Capodanno","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.09.1227_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jcin.2020.02.036","article-title":"Pre-treatment with oral P2Y12 inhibitors in non-ST-segment elevation acute coronary syndromes: does one size fit all?","volume":"13","author":"Ferreiro","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.09.1227_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.09.1227_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.09.1227_bib6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and Sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.09.1227_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes","volume":"369","author":"Montalescot","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.09.1227_bib8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.09.1227_bib9","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jacc.2020.08.053","article-title":"Timing of oral P2Y12 inhibitor administration in patients with non-ST-segment elevation acute coronary syndrome","volume":"76","author":"Tarantini","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib10","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.09.1227_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.09.1227_bib13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.09.1227_bib14","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.09.1227_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.18735","article-title":"Association of pretreatment with P2Y12 receptor antagonists preceding percutaneous coronary intervention in non-ST-segment elevation acute coronary syndromes with outcomes","volume":"3","author":"Dworeck","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.09.1227_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2023.05.025","article-title":"European practice patterns for antiplatelet management in NSTE-ACS patients: results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey","volume":"386","author":"Angiolillo","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCOUTCOMES.108.847145","article-title":"A\u00a0call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction","volume":"2","author":"Peterson","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.09.1227_bib18","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib19","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2022.02.034","article-title":"The National Cardiovascular Data Registry Data Quality Program. 2020","volume":"79","author":"Malenka","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjcard.2010.12.009","article-title":"In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry\u00ae-GWTG","volume":"107","author":"Mathews","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcin.2023.10.064","article-title":"Pretreatment with P2Y12 inhibitors in ST-segment elevation myocardial infarction","volume":"17","author":"Rohla","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.09.1227_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/eurheartj\/ehx255","article-title":"Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy","volume":"39","author":"Doll","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.09.1227_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006275","article-title":"Physician and hospital utilization of P2Y12 inhibitors in ST-segment-elevation myocardial infarction in the United States: a study from the National Cardiovascular Data Registry's Research to Practice Initiative","volume":"13","author":"Faridi","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.09.1227_bib25","article-title":"Precatheterization use of P2Y12 inhibitors in non-ST-elevation myocardial infarction patients undergoing early cardiac catheterization and in-hospital coronary artery bypass grafting: insights from the National Cardiovascular Data Registry(\u00ae)","volume":"6","author":"Badri","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.09.1227_bib27","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.jcin.2017.07.020","article-title":"Variation in the adoption of transradial access for ST-segment elevation myocardial infarction: insights from the NCDR CathPCI Registry","volume":"10","author":"Valle","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.09.1227_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archinternmed.2012.394","article-title":"Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry","volume":"172","author":"Matlock","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.09.1227_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2021.11.061","article-title":"Variability in coronary artery disease testing for patients with new-onset heart failure","volume":"79","author":"Zheng","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.0006-341X.2000.00909.x","article-title":"Interpreting parameters in the logistic regression model with random effects","volume":"56","author":"Larsen","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2024.09.1227_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jech.2004.029454","article-title":"A\u00a0brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena","volume":"60","author":"Merlo","year":"2006","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.jacc.2024.09.1227_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003741","article-title":"Practice patterns and in-hospital outcomes associated with bivalirudin use among patients with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention in the United States","volume":"10","author":"Secemsky","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.09.1227_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamacardio.2018.4472","article-title":"Association of physician variation in use of manual aspiration thrombectomy with outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: The National Cardiovascular Data Registry CathPCI Registry","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib34","series-title":"Identification and Inference for Econometric Models: Essays in Honor of Thomas Rothenberg","first-page":"80","article-title":"Testing for weak instruments in linear IV regression","author":"Stock","year":"2005"},{"key":"10.1016\/j.jacc.2024.09.1227_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pds.1908","article-title":"Instrumental variable methods in comparative safety and effectiveness research","volume":"19","author":"Brookhart","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2024.09.1227_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.34322","article-title":"Assessment of pretreatment with oral P2Y12 inhibitors and cardiovascular and bleeding outcomes in patients with non-ST elevation acute coronary syndromes: a systematic review and meta-analysis","volume":"4","author":"Dawson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.09.1227_bib37","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.jacc.2020.10.010","article-title":"Non-ST-segment elevation acute coronary syndrome: the last nail in the coffin of pre-treatment","volume":"76","author":"Montalescot","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.09.1227_bib38","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.jacc.2024.04.036","article-title":"Timing of P2Y(12) inhibitor administration in patients with STEMI undergoing primary PCI","volume":"83","author":"Almendro-Delia","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724098437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724098437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:15:46Z","timestamp":1785788146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724098437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0735109724098437"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.09.1227","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 Inhibitor Pretreatment in Non\u2013ST-Segment Elevation Acute\u00a0Coronary Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.09.1227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}